INDIA BUILDING UP
EFFORTS FOR VACCINE R&D
COVER
DESIGN BY:
DOMINIX STRATEGIC
DESIGN PVT. LTD.
NEHA METHA
The Indian vaccine industry began as a network of state-owned manufacturers supplying basic
pediatric vaccines to the national immunization programme. In recent times, the number of private
owned firms active in the sector has grown rapidly. Their success in bringing low cost vaccine
solutions to the public vaccine market is an important driver behind the emergence of the sector. As
the industry is becoming more sophisticated, there is an increasing focus on innovation. Across the industry, a dozen or so new vaccines are in clinical development.
The BioSpectrum India edition was launched in March 2003 and is India's first comprehensive biotech business monthly magazine. It provides comprehensive coverage of the exciting happenings in life sciences, which include BioPharma, BioAgriculture, BioInformatics, BioIndustrial, BioSuppliers and BioServices and show cases the emerging Indian entrepreneurships in biotech industry. In a short time BioSpectrum has emerged as the most preferred platform to engage the life sciences industry in India and Asia Pacific. It is also widely accepted by research and academia community. Top key policy makers in the Central and state government use the magazine as a platform to reach out the Indian Biotech Industry. BioSpectrum has columns by Indian's top policy makers, biotechnology professionals, scientists and NGOs. Readers of BioSpectrum are from among the key Policy Makers, Key Executives and the Influencer's in Biotechnology, Pharmaceutical Companies, Research Heads of Clinical Research, Clinical Trials and Contract Mfg Organizations, Educational Institutes, Consultants, Fund Managers etc
